This project will use near-infrared labeled probes to visualize endothelial proliferation. The labeled compound of choice is GSAO which is a trivalent arsenical molecule with a specificity for the proliferating endothelium.

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC010372-01
Application #
6557473
Study Section
(RO)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Russo, Andrea L; Jedlicka, Kimberly; Wernick, Meredith et al. (2009) Urine analysis and protein networking identify met as a marker of metastatic prostate cancer. Clin Cancer Res 15:4292-8
Simone, Nicole L; Menard, Cynthia; Soule, Benjamin P et al. (2008) Intrarectal amifostine during external beam radiation therapy for prostate cancer produces significant improvements in Quality of Life measured by EPIC score. Int J Radiat Oncol Biol Phys 70:90-5
Russell, Jeffery S; Brady, Kristin; Burgan, William E et al. (2003) Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res 63:7377-83
Camphausen, Kevin; Moses, Marsha A; Menard, Cynthia et al. (2003) Radiation abscopal antitumor effect is mediated through p53. Cancer Res 63:1990-3
Chan, Linda W; Camphausen, Kevin (2003) Angiogenic tumor markers, antiangiogenic agents and radiation therapy. Expert Rev Anticancer Ther 3:357-66